Home Healthcare IT Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market Size, Share & Trends Analysis Report By Procedure (Preimplantation Genetic Screening (PGS), Preimplantation Genetic Diagnosis (PGD)), By Product (Reagents and Consumables, Instruments, Software), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridisation (FISH), Others), By Application (Chromosomal Abnormalities, Aneuploidy Screening, X-linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Others), By End-User (Hospitals, Fertility Centres, Diagnostic Centres, Research Centres and Academic Labs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SRHI296DR | Pages: 158
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Preimplantation Genetic Testing Market Size Analysis
    1. Global Preimplantation Genetic Testing Market Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
    7. U.S.
      1. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Preimplantation Genetic Screening (PGS)
          1. By Value
        3. Preimplantation Genetic Diagnosis (PGD)
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Reagents and Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Software
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Fluorescent In Situ Hybridisation (FISH)
          1. By Value
        5. Others
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Chromosomal Abnormalities
          1. By Value
        3. Aneuploidy Screening
          1. By Value
        4. X-linked Diseases
          1. By Value
        5. Embryo Testing
          1. By Value
        6. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Fertility Centres
          1. By Value
        4. Diagnostic Centres
          1. By Value
        5. Research Centres and Academic Labs
          1. By Value
    8. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
    7. U.K.
      1. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Preimplantation Genetic Screening (PGS)
          1. By Value
        3. Preimplantation Genetic Diagnosis (PGD)
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Reagents and Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Software
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Fluorescent In Situ Hybridisation (FISH)
          1. By Value
        5. Others
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Chromosomal Abnormalities
          1. By Value
        3. Aneuploidy Screening
          1. By Value
        4. X-linked Diseases
          1. By Value
        5. Embryo Testing
          1. By Value
        6. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Fertility Centres
          1. By Value
        4. Diagnostic Centres
          1. By Value
        5. Research Centres and Academic Labs
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
    7. China
      1. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Preimplantation Genetic Screening (PGS)
          1. By Value
        3. Preimplantation Genetic Diagnosis (PGD)
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Reagents and Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Software
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Fluorescent In Situ Hybridisation (FISH)
          1. By Value
        5. Others
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Chromosomal Abnormalities
          1. By Value
        3. Aneuploidy Screening
          1. By Value
        4. X-linked Diseases
          1. By Value
        5. Embryo Testing
          1. By Value
        6. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Fertility Centres
          1. By Value
        4. Diagnostic Centres
          1. By Value
        5. Research Centres and Academic Labs
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
    7. UAE
      1. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Preimplantation Genetic Screening (PGS)
          1. By Value
        3. Preimplantation Genetic Diagnosis (PGD)
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Reagents and Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Software
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Fluorescent In Situ Hybridisation (FISH)
          1. By Value
        5. Others
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Chromosomal Abnormalities
          1. By Value
        3. Aneuploidy Screening
          1. By Value
        4. X-linked Diseases
          1. By Value
        5. Embryo Testing
          1. By Value
        6. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Fertility Centres
          1. By Value
        4. Diagnostic Centres
          1. By Value
        5. Research Centres and Academic Labs
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Procedure
      1. Introduction
        1. Procedure By Value
      2. Preimplantation Genetic Screening (PGS)
        1. By Value
      3. Preimplantation Genetic Diagnosis (PGD)
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Reagents and Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Software
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Next-Generation Sequencing (NGS)
        1. By Value
      3. Polymerase Chain Reaction (PCR)
        1. By Value
      4. Fluorescent In Situ Hybridisation (FISH)
        1. By Value
      5. Others
        1. By Value
    5. By Application
      1. Introduction
        1. Application By Value
      2. Chromosomal Abnormalities
        1. By Value
      3. Aneuploidy Screening
        1. By Value
      4. X-linked Diseases
        1. By Value
      5. Embryo Testing
        1. By Value
      6. Human Leukocyte Antigen (HLA) Typing
        1. By Value
      7. Others
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Fertility Centres
        1. By Value
      4. Diagnostic Centres
        1. By Value
      5. Research Centres and Academic Labs
        1. By Value
    7. Brazil
      1. By Procedure
        1. Introduction
          1. Procedure By Value
        2. Preimplantation Genetic Screening (PGS)
          1. By Value
        3. Preimplantation Genetic Diagnosis (PGD)
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Reagents and Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Software
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Next-Generation Sequencing (NGS)
          1. By Value
        3. Polymerase Chain Reaction (PCR)
          1. By Value
        4. Fluorescent In Situ Hybridisation (FISH)
          1. By Value
        5. Others
          1. By Value
      4. By Application
        1. Introduction
          1. Application By Value
        2. Chromosomal Abnormalities
          1. By Value
        3. Aneuploidy Screening
          1. By Value
        4. X-linked Diseases
          1. By Value
        5. Embryo Testing
          1. By Value
        6. Human Leukocyte Antigen (HLA) Typing
          1. By Value
        7. Others
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Fertility Centres
          1. By Value
        4. Diagnostic Centres
          1. By Value
        5. Research Centres and Academic Labs
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
  14. Competitive Landscape
    1. Preimplantation Genetic Testing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Oxford Gene Technology
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. SciGene Corporation
    4. Agilent Technologies Inc.
    5. PerkinElmer Inc.
    6. Coopersurgical Inc.
    7. Abbott Laboratories
    8. Illumina Inc.
    9. Natera Inc
    10. Yikon Genomics
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.